trending Market Intelligence /marketintelligence/en/news-insights/trending/5noIlmx8uy1T6reqJ17d9A2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Endo settles opioid claims with Oklahoma for $8.75M

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Endo settles opioid claims with Oklahoma for $8.75M

Endo International PLC has reached an $8.75 million settlement with Oklahoma officials to resolve the generics and specialty pharmaceutical company's role in ongoing litigation over the U.S. opioid epidemic.

Malvern, Pa.-based Endo and its subsidiaries, Endo Pharmaceuticals Inc. and Par Pharmaceutical Inc., agreed with the state to settle all claims and resolve the investigation into the company's involvements in the opioid abuse crisis, according to a Jan. 10 press release. The company's senior leadership reached the agreement with Oklahoma Attorney General Mike Hunter and staff.

The settlement does not include an admission of any wrongdoing on the part of Endo.

A number of companies have reached settlements with states to resolve claims that certain marketing practices fueled the opioid epidemic, which kills about 200 Americans each day.